Brief report: Reclassifying SCLC-Y as SMARCA4 deficient malignancies - resolving the controversy
J. Ng, L. Cai, L. Girard, O. Prall, N. Rajan, C. Khoo, A. Batrouney, A. Kersbergen, M. Christie, J. Minna, M. L. Burr, K. D. Sutherland
The paper reclassifies YAP1-expressing SCLC-Y as SMARCA4-deficient malignancies, showing they lack SCLC features and instead resemble SMARCA4-deficient tumors.
bioRxiv · Oct 9, 2022Cancer Biology